[an error occurred while processing this directive] ����Ƥ���Բ�ѧ��־ 2007, 33(6) 323-325 DOI:     ISSN: 2096-5540 CN: 32-1880/R

����Ŀ¼ | ����Ŀ¼ | ������� | �߼�����                                                            [��ӡ��ҳ]   [�ر�]
����
��չ����
������Ϣ
Supporting info
PDFȫ��
[HTMLȫ��]
�����
�����뷴��
�ѱ����Ƽ�������
�����ҵ����
�������ù�����
����
Email Alert
���·���
���������Ϣ
���Ĺؼ����������
���������ۺ���
��������
����
���������������
����Ӣ
����Ӣ
PubMed
Article by FENG Su-ying
Article by JIN Pei-ying

�����ۺ���25������

����Ӣ, ����Ӣ

�й�ҽѧ��ѧԺƤ�����о���, 210042

ժҪ��

Ŀ�� ����25�������ۺ������ߵ��ٴ��ص�����Ʒ��������� �ع��Է���25�������ۺ������ߵ��ٴ����ϡ���� �۾������������������Զ��,��߷�����Ϊ��׳��(25��40��),��������ʵ����ָ��,��������Ʒ����н��������߷�Ӧ�����ס����ư�ϸ��������ҩ���������á����ݻ��ߵIJ���,������ҩ��������,�Ӷ��������ֹ�����ķ����ͷ�չ,ҩ���ά�ֺͲ�����Ӧ�ļ��Լ�������Ҳ����Ҫ������ �����ۺ����ǿ��Կ��Ƶ�һ��Ƥ��Ѫ���ײ���

�ؼ����� ���������ۺ���   ��������   ����  

Clinical analysis of 25 cases of Behcet syndrome

Institute of Dermatology, Chinese Academy of Medical Sciences, Nanjing 210042, China

Institute of Dermatology, Chinese Academy of Medical Sciences, Nanjing 210042, China

Abstract:

Objective To study the clinical features and treatment strategy in patients with Behcet syndrome. Methods Clinical data on 25 cases of Behcet syndrome were analyzed retrospectively. Results Eye and genital involvements were mostly observed in male patients with Behcet syndrome. The peak onset age of the disease ranged from 25 to 40 years. There was no specific laboratory index for Behcet syndrome, and misdiagnosis was common. The combination of drugs to inhibit immunoreactions, inflammation and leukocyte chemotaxis could be used in the treatment of Behcet syndrome. It was also very important to maintain treatment and monitor adverse reactions of drugs. Conclusion Behcet syndrome is a kind of controllable cutaneous vasculitis.

Keywords: Behcet syndrome   Disease attributes   Therapy  
�ո����� 2007-07-16 �޻�����  ����淢������  
DOI:
������Ŀ:

ͨѶ����: ����Ӣ, email:jinpeiying@medmail.com.cn
���߼��:

�ο����ף�
[1] AL-Otaibi LM,Porter SR Poate TE.Behcet's disease a review.J Dent Res,2005,84(3):209-222.
[2] Evereklioglu C.Current concepts in the etiology and treatment of Beheet disease.Surv Ophthalmol,2005,50(4):297-350.
[3] Gul A.Behcet's disease as an autoinflammatory disorder.Curr Drug Targets lnflamm Allergy,2005,4(1):81-83.
[4] ��Ӣ��,������,�Ϲ��,��.�����ۺ���64������.�л�Ƥ������־,2005,739(6):314-316.
�������������
1���󸶹�,����,������.�����ۺ��������ķ��ӻ��Ƶ��о���չ[J]. ����Ƥ���Բ�ѧ��־, 2006,32(1): 35-
2����Ԫ��.�ձ����޶��İ����ۺ����������ڼ��ٴ����س̶ȱ�׼[J]. ����Ƥ���Բ�ѧ��־, 2006,32(1): 57-
3��������, ������.�������������Ŵ������о���չ[J]. ����Ƥ���Բ�ѧ��־, 0,(): 376-377
4�����Ŀ�, ���̸�.��������ijЩ���ƽ�չ[J]. ����Ƥ���Բ�ѧ��־, 2005,31(1): 24-26
5��������, ������.�������������Ŵ������о���չ[J]. ����Ƥ���Բ�ѧ��־, 0,(): 376-377
6������Ӣ, ����Ӣ.�����ۺ���25������[J]. ����Ƥ���Բ�ѧ��־, 0,(): 323-325
7��������, ������.�������������Ŵ������о���չ[J]. ����Ƥ���Բ�ѧ��־, 2005,31(6): 376-377

�������� (��ע��:��վʵ�������Ը�, �벻Ҫ������ѧ���޹ص�����!�������ݲ�����վ�۵�.)

Copyright 2008 by ����Ƥ���Բ�ѧ��־